| Literature DB >> 28127166 |
Triveni M Nalawade1, Kishore G Bhat2, Suma Sogi3.
Abstract
AIMS: The aim of this study was to determine the relative antimicrobial effectiveness of these endodontic medicaments and various vehicles using an agar well diffusion assay.Entities:
Keywords: Agar well diffusion; Medicaments; Minimum inhibitory concentration; Vehicles.
Year: 2016 PMID: 28127166 PMCID: PMC5233701 DOI: 10.5005/jp-journals-10005-1388
Source DB: PubMed Journal: Int J Clin Pediatr Dent ISSN: 0974-7052
Figs 1A to D:Minimum inhibitory concentration of single antimicrobial substances, i.e.: (A) Chlorhexidine gluconate; (B) ciprofloxacin; (C) amoxicillin clavulanate; and (D) metronidazole by broth dilution method against P. gingivalis
Figs 2A and B:Minimum inhibitory concentration of combination of antimicrobial substances, i.e.: (A) Ciprofloxacin with metronidazole; and (B) amoxicillin clavulanate with metronidazole by broth dilution method against P. gingivalis
Figs 3A to C:Antimicrobial activity of the endodontic medicaments, i.e.: (A) 2% chlorhexidine gluconate; (B) ciprofloxacin with metronidazole; and (C) amoxicillin clavulanate with metronidazole along with the four vehicle combinations against P. gingivalis using agar well diffusion method
Table 1: Minimum inhibitory concentration of single antimicrobial substances by broth dilution method
| Chlorhexidine | 0.078% | ||||
| 0.078% | |||||
| 0.156% | |||||
| 0.019% | |||||
| 0.078% | |||||
| Ciprofloxacin | 7.81 μg/mL | ||||
| 31.25 μg/mL | |||||
| 1.95 μg/mL | |||||
| 0.019 μg/mL | |||||
| 1.95 μg/mL | |||||
| Amoxicillin clavulanate | 7.8125 μg/mL | ||||
| 3.90 μg/mL | |||||
| 15.625 μg/mL | |||||
| 0.019 μg/mL | |||||
| 15.625 μg/mL | |||||
| Metronidazole | 500 μg/mL | ||||
| 500 μg/mL | |||||
| 500 μg/mL | |||||
| 0.975 μg/mL | |||||
| 1 μg/mL |
Table 2: Minimum inhibitory concentration of combination of antimicrobial substances by broth dilution method
| Ciprofloxacin + Metronidazole | 1.95 μg/mL | ||||
| 7.81 μg/mL | |||||
| 1.95 μg/mL | |||||
| 0.039 μg/mL | |||||
| 1.95 μg/mL | |||||
| Amoxicillin clavulanate + | 3.90 μg/mL | ||||
| Metronidazole | 15.625 μg/mL | ||||
| 15.625 μg/mL | |||||
| 0.019 μg/mL | |||||
| 15.625 μg/mL |
Table 3: Antimicrobial activity of the endodontic medicaments and vehicle combinations against selected pathogens using agar well diffusion method
| S. | S. | ||||||||||
| Chlorhexidine | PEG | 31.00 (1.00) | 39.00 (1.00) | 31.67 (1.52) | 26.00 (1.00) | ||||||
| PG | 32.00 (1.00) | 37.67 (1.15) | 29.33 (0.57) | 27.00 (1.00) | |||||||
| PG +PEG | 31.33 (0.57) | 37.33 (1.52) | 29.67 (1.52) | 27.33 (0.57) | |||||||
| Glycerine | 31.33 (0.57) | 35.67 (0.57) | 28.00 (1.00) | 27.67 (1.52) | |||||||
| H-Value# | 1.96 | 7.30 | 6.79 | 3.37 | |||||||
| p-value | 0.58 (NS) | 0.063 (NS) | 0.079 (NS) | 0.337 (NS) | |||||||
| C+M | PEG | - | 25.00 (1.00) | 34.00 (1.00) | 37.00 (1.00) | ||||||
| PG | - | 24.00 (1.00) | 33.00 (1.00) | 38.33 (0.57) a | |||||||
| PG +PEG | - | 24.00 (1.00) | 33.00 (1.00) | 39.00 (1.00) | |||||||
| Glycerine | - | 23.67 (0.57) | 32.67 (0.57) | 32.33 (1.52) a | |||||||
| H-Value# | 3.041 | 3.041 | 9.00 | ||||||||
| p-value | 0.385 (NS) | 0.385 (NS) | 0.029* | ||||||||
| A+M | PEG | 25.00 (1.00) | 27.00 (1.00) | 26.00 (1.00) | 46.00 (1.00) | ||||||
| PG | 26.33 (0.57) | 27.00 (1.00) | 25.33 (1.52) | 46.33 (1.52) | |||||||
| PG +PEG | 25.33 (2.08) | 26.67 (1.52) | 27.33 (.57) | 46.00 (1.00) | |||||||
| Glycerine | 20.00 (1.00) | 25.00 (1.00) | 28.00 (1.00) | 45.00 (1.00) | |||||||
| H-Value# | 7.56 | 4.44 | 6.72 | 2.11 | |||||||
| p-value | 0.056 (NS) | 0.217 (NS) | 0.081 (NS) | 0.548 (NS) |
#Kruskal Wallis test; p > 0.05 non significant (NS); *p < 0.05 significant; apairwise comparison using post hoc Mann Whitney U test statistically significant p < 0.05). All other pairwise comparisons are non significant (NS)